methylphenidate has been researched along with Myopia in 1 studies
Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.
Myopia: A refractive error in which rays of light entering the EYE parallel to the optic axis are brought to a focus in front of the RETINA when accommodation (ACCOMMODATION, OCULAR) is relaxed. This results from an overly curved CORNEA or from the eyeball being too long from front to back. It is also called nearsightedness.
Excerpt | Relevance | Reference |
---|---|---|
"What's known Myopia is spreading rapidly in technologically advanced societies." | 5.62 | Effect of methylphenidate as a dopaminergic agent on myopia: Pilot study. ( Gurlevik, U; Kara, H; Yasar, E, 2021) |
"What's known Myopia is spreading rapidly in technologically advanced societies." | 1.62 | Effect of methylphenidate as a dopaminergic agent on myopia: Pilot study. ( Gurlevik, U; Kara, H; Yasar, E, 2021) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Gurlevik, U | 1 |
Kara, H | 1 |
Yasar, E | 1 |
1 other study available for methylphenidate and Myopia
Article | Year |
---|---|
Effect of methylphenidate as a dopaminergic agent on myopia: Pilot study.
Topics: Dopamine; Female; Humans; Male; Methylphenidate; Myopia; Pilot Projects; Refraction, Ocular | 2021 |